Company intelligence / Profile preview

Mendel Biotechnology

Hayward, California, United Statesmbi-holdings.com ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Mendel Biotechnology developed proprietary platforms for the discovery and commercialization of genetic traits that improve crop productivity, stress tolerance, resource use efficiency, and other agronomic characteristics. The company's technology was commercialized through partnerships with major agri-businesses before its R&D division was acquired by Koch Agronomic Services in 2014.

Modalities: Genetic trait engineeringSmall molecule
Industry: Agriculture & AgTech

Partnerships

Monsanto CorporationBPBayer CropScience

Beyond the preview

Go deeper on Mendel Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mendel Biotechnology.

Explore the full profile